- New preclinical stage prostate cancer drug inhibits prostate tumor growth and metastasis in a different mode of action than current anti-cancer drugs
inhibits human prostate cancer cell metastasis as efficiently as combretastatin
- Morphinan-6-ones for the treatment of neurodegenerative diseases
compounds exhibit pro-cholinergic properties but avoid opioid receptor agonism
- Abbott is seeking vascular and eye devices and diagnostic products diabetes
Coronary, Endovascular, and Vessel closure devices, Corneal, Refractive, and Cataract products, Molecular diagnostics, Glucose monitoring, Diabetes management
- Nycomed is looking for early stage pain, respiratory and gastrointestinal inflammation products
near to market: Respiratory, Gastrointestinal, Inflammation, Pain, Osteoporosis, Tissue management
- Artificial enzymes - Unique platform technology for production of polymer bound organocatalysts
enables optimal enzymatic conditions due to the production method ability to mimic natural enzymes
© 2006-2007
by Herbert-Worch-Foundation
print this page
